Literature DB >> 8672743

Prevalence of gastric ulcer in cirrhotic patients and its relation to portal hypertension.

L S Chen1, H C Lin, S J Hwang, F Y Lee, M C Hou, S D Lee.   

Abstract

The prevalence of gastric ulcer and its relationship to the severity of cirrhosis and degree of portal hypertension was evaluated in 245 cirrhotic patients, and compared with 245 age- and sex-matched healthy subjects. Portal and systemic haemodynamic studies were performed in cirrhotic patients. The prevalence of gastric ulcer in cirrhotic patients was 20.8%, which was significantly higher than the 4.0% found in healthy controls. Using a multivariate logistic regression model, the hepatic venous pressure gradient was found to be the only predictor of the prevalence of gastric ulcer in cirrhotic patients to present with gastric ulcer. The hepatic venous pressure gradient was significantly higher in cirrhotic patients with gastric ulcer than in those without (17.3 +/- 4.4 vs 15.5 +/- 5.0 mmHg, P = 0.01). Other variables, including sex, smoking, cardiac output and severity or aetiology of cirrhosis did not show significant differences between the two patient groups. The prevalence of gastric ulcer in cirrhotic patients whose hepatic venous pressure gradient was below 12 mmHg (4.5%) was similar to that observed in the healthy controls (4.0%). However, when the hepatic venous pressure gradient was > 12 mmHg, the prevalence of gastric ulcer (24.4%) was significantly higher than that in control subjects. However, the incidence of gastric ulcer was not related to the degree of portal hypertension. In conclusion, the prevalence of gastric ulcer in cirrhotic patients was found to be significantly higher than in the age- and sex-matched healthy subjects. Portal hypertension with a hepatic venous pressure gradient > 12 mmHg may be an important factor contributing to the increased prevalence of gastric ulcer observed in patients with liver cirrhosis.

Entities:  

Mesh:

Year:  1996        PMID: 8672743     DOI: 10.1111/j.1440-1746.1996.tb00011.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  23 in total

1.  Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients.

Authors:  I A Scotiniotis; M R Lucey; D C Metz
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

2.  Distinctive aspects of peptic ulcer disease, Dieulafoy's lesion, and Mallory-Weiss syndrome in patients with advanced alcoholic liver disease or cirrhosis.

Authors:  Borko Nojkov; Mitchell S Cappell
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

3.  Impact of multi-approach strategy on acid suppressive medication use in a teaching hospital in Qatar.

Authors:  Imran F Khudair; Nagham D Sadik; Yolande Hanssens; Saif A Muhsin; Issa Matar
Journal:  Int J Clin Pharm       Date:  2011-07-02

4.  [Personnel calculation in health care: intensive care and intermediate care units].

Authors:  W Plücker
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-10-15       Impact factor: 0.840

Review 5.  Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives.

Authors:  Gyu Sang Yoo; Jeong Il Yu; Hee Chul Park
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

Review 6.  Update of endoscopy in liver disease: more than just treating varices.

Authors:  Christoforos Krystallis; Gail S Masterton; Peter C Hayes; John N Plevris
Journal:  World J Gastroenterol       Date:  2012-02-07       Impact factor: 5.742

Review 7.  Gastrointestinal dysfunction in liver cirrhosis.

Authors:  Evangelos Kalaitzakis
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 8.  Avoiding pitfalls: what an endoscopist should know in liver transplantation--part 1.

Authors:  Sharad Sharma; Ahmet Gurakar; Nicolas Jabbour
Journal:  Dig Dis Sci       Date:  2007-11-09       Impact factor: 3.199

9.  Predictive factors for gastroduodenal toxicity based on endoscopy following radiotherapy in patients with hepatocellular carcinoma.

Authors:  H Yoon; D Oh; H C Park; S W Kang; Y Han; D H Lim; S W Paik
Journal:  Strahlenther Onkol       Date:  2013-05-25       Impact factor: 3.621

Review 10.  Proton pump inhibitors in cirrhosis: tradition or evidence based practice?

Authors:  Francesca Lodato; Francesco Azzaroli; Maria Di Girolamo; Valentina Feletti; Paolo Cecinato; Andrea Lisotti; Davide Festi; Enrico Roda; Giuseppe Mazzella
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.